ILOZYME: PANCRELIPASE TABLETS.
The PANCRELIPASE TABLETS is a the manufacturer industrial component. Key specifications include administration: ORAL, primary_container_type: BOTTLE, medical_designation_and_grade: UNITED STATES PHARMACOPEIA, primary_container_content_quantity: 250.000 TABLETS. This part is cataloged in the U.S.
Government catalog under NSN 6505-01-101-8922, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.
Verify compatibility with your specific system configuration before ordering.
| administration | ORAL |
| primary_container_type | BOTTLE |
| medical_designation_and_grade | UNITED STATES PHARMACOPEIA |
| primary_container_content_quantity | 250.000 TABLETS |
| active_medicament_medicinal_strength | 30000.000 USP UNITS AMYLASE ACTIVE INGREDIENT AND 11000.000 USP UNITS LIPASE ACTIVE INGREDIENT AND 30000.000 USP UNITS PROTEASE ACTIVE INGREDIENT |
| NSN | 6505-01-101-8922 |
| ADMINISTRATION | ORAL |
| PRIMARY CONTAINER CONTENT QUANTITY | 250.000 TABLETS |
| MEDICAL DESIGNATION AND GRADE | UNITED STATES PHARMACOPEIA |
| PRIMARY CONTAINER TYPE | BOTTLE |
| ACTIVE MEDICAMENT MEDICINAL STRENGTH | 30000.000 USP UNITS AMYLASE ACTIVE INGREDIENT AND 11000.000 USP UNITS LIPASE ACTIVE INGREDIENT AND 30000.000 USP UNITS PROTEASE ACTIVE INGREDIENT |
No substitute or cross-reference records for this part.